09 March 2021
Visiongain has published a new report on 4D Printing in Healthcare Market Report to 2031: Forecasts by Component (Equipment, 3D Printers, 3D Bioprinters, Programmable Materials, Shape-memory Materials, Hydrogels, Living cells, Software & Services), By Technology (FDM, PolyJet, Stereolithography, and SLS), By Application (Medical Models, Surgical Guides, and Patient-specific Implants), By End-User (Hospitals & Clinics, Dental Laboratories, and Other End-Users) PLUS COVID-19 Recovery Scenarios
Global 4D printing in the healthcare market size is projected to reach US$ XX Million in 2021 and is expected to display strong revenue growth through to 2031.
COVID-19 Impact on 4D Printing in Healthcare Market
The COVID-19 pandemic has deleteriously affected all the countries and industries. Similarly, 4D printing in the healthcare market is anticipated to take a hit. The target industry is now facing challenges to manage the interrupted demand and supply of components. Also, unpredictable and disturbing supply chain activities and the unavailability of human resources are anticipated to impact the target industry growth. In contrast, the rising research & development activities for developing novel treatments against COVID-19 is creating a lucrative opportunity for the companies. Hence, the overall COVID-19 impact is expected to continue to moderate for the global key players operating in the industry.
Extensive Use of 4D Printing Technology to Trigger Market Growth
4D printing technology finds an abundant scope of use in the medical industry and has brought in a significant revolution in the healthcare industry. It has broadened its scope of application in chemotherapy, self-assembling human-scale biomaterials, and tissue engineering. Due to the constant technological advancement, there is a shift from 3D medical devices to 4D ones for example stents, biomedical splint, bioprinting, and orthodontic devices.
The 4D printing in the healthcare market growth is ascribed to its wide-ranging applications in the medical industry. These 4D models could simply be personalized according to the patient’s pathology thus offering an opportunity for making patient care effective and efficient. 4D technology has shown its capability in the creation of smart medical models that will transform the medical industry completely. Targeted drug delivery is the major application where the therapeutic drug is delivered in a specific location of the human body. To accomplish this, 4D printed devices are proficient in carrying therapeutic drugs to the targeted location when it activates the precise stimuli. These devices are also proficient in working on many possible stimuli. For that reason, it is forecast that 4D printing will boost the growth of the healthcare industry in the given timeframe.
Growing Application of 4D Printing in Verticals such as Implants, Dentistry, and Prosthetics.
The dental industry is a major application of 4D printing. For instance, Clear aligners are engaged in the manufacturing of products thru 3D printing in the dental industry. The company is aiming to further enhance its products by using 4D printing, as these products need shape-altering properties as per the altering structure of the teeth every week. On the other hand, Align technology uses 3D Systems to produce over 1.6 million custom aligners every week.
Growing application of 4D printers in dental implants such as dentures, bridges, crowns, etc. are creating lucrative opportunities for the target industry growth. The rising occurrence of dental diseases is fuelling the target market growth further. In 2018, the World Health Organization (WHO) said that oral disorders have affected around 3.7 billion people that is nearly half of the world’s population.
Rising Research and Development and Growing Investment by Chemical Companies
In March 2019, a research team from the U.S. designed a new bio-ink that permits printing catalytically active live cells into numerous self-sustaining 3D geometries. It has properties such as fine filament thickness, high catalytic productivity, and tunable cell densities.
Several companies have financed Chinese 3D printing companies to expand their business in the global market. For example, in November 2018, BASF publicized that the company has invested in Prismlab. Prismlab has designed a patented printing process that has greater accuracy, high printing speed, and low cost. BASF’s venture funding will help to speed up its product development and invention while strengthening its reach to the global market.
Key players operating in the 4D Printing in the Healthcare market are 3D Systems, Inc., Anatomiz3D Medtech Private Limited, Organovo Holdings Inc., CELLINK, Osteo3d, Stratasys Ltd., Materialise, Dassault Systèmes, EOS, EnvisionTEC, Poietis - 4D Bioprinting Tractus3D, Allevi, 3D HUBS B.V., axial3D - Medical 3D Printing Experts Ltd., Formlabs and Sinterex.
The key players have adopted new product development, product launches, product approval, agreement, partnerships, and merger as its key business development strategies to tap into the global 4D Printing in the Healthcare market. For instance, in August 2019, Researchers at ETH Zurich have developed a ground-breaking method for making malleable microstructures by using 4D printing. For example, vascular stents that are 40X smaller than earlier possible and will be helpful to broaden fatal restraints of the urinary tract in the fetus.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.
31 January 2023
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
31 January 2023
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
31 January 2023
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.